Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Connect Twitter with Market Wire News

ATOS Quote, Trading Chart, Atossa Genetics Inc.


home / stock / atos / atos quote

$0.8509 Last:

-3.33% Change Percent:

$0.89 Open:

$0.8509 Previous Close:

$0.8989 High:

$0.8351 Low:

1,636,768 Volume:

05/25/2022 04:53:23 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

ATOS Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-05-250.890.85090.89890.83511,636,768
2022-05-240.910.88020.910.871,355,178
2022-05-230.97180.91330.97180.90221,160,821
2022-05-200.96190.95940.98520.92231,115,808
2022-05-190.9570.9570.9880.9442983,633
2022-05-180.98480.9571.020.94221,366,335
2022-05-170.981.011.030.9722829,832
2022-05-160.990.97541.020.964713,027
2022-05-130.94460.98631.030.941,319,649
2022-05-120.90.92990.960.88351,299,263
2022-05-110.960.90571.010.8911,679,654
2022-05-100.95070.98381.010.9361,706,144
2022-05-090.96190.950.99970.93511,772,765
2022-05-060.960.98571.020.95051,313,662
2022-05-0510.97211.010.961,610,357
2022-05-041.011.031.030.971,136,982
2022-05-031.020.9821.040.9721,167,954
2022-05-021.011.011.0350.9861,483,193
2022-04-291.051.011.080.991,945,009
2022-04-281.121.041.121.022,304,167
Stock Information

Atossa Genetics Inc. Company Name:

ATOS Stock Symbol:

NASDAQ Market:

Atossa Genetics Inc. Website:

ATOS Quote, Trading Chart, Atossa Genetics Inc.

MENU
ATOS ATOS Quote ATOS Short ATOS News ATOS Articles ATOS Message Board
Get ATOS Alerts

News, Short Squeeze, Breakout and More Instantly...

Connect Twitter with Market Wire News
RECENT ATOS NEWS
  • ATOS - Atossa Therapeutics to Present at the H.C. Wainwright Global Hybrid Investment Conference

    SEATTLE, May 18, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative proprietary medicines in areas of significant unmet medical need in oncology and infectious disease with a current focus on breast can...

  • ATOS - Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update

    SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces financial...

  • ATOS - Atossa Therapeutics to Present at the Q2 Investor Summit Conference

    SEATTLE, April 27, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and C...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Discord

Join us on Discord

Follow us on discord to get immediate notifications!

Check out the New Market Wire News Discord Bot

Discord


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email [email protected].

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected
Follow @MarketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News